Estrogen preserves split renal function in a chronic complete unilateral ureteral obstruction animal model

Experimental and Therapeutic Medicine

Volumn 7, Issue 6, 2014, Pages 1555-1562

  Mao, Shanhua ^a   Xu, Hua ^a   Zou, Lujia ^a   Xu, Gang ^a   Wu, Zhong ^a   Ding, Qiang ^a   Jiang, Haowen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Estrogen; Glomerular filtration rate; Rat; Split renal function; Ureteral obstruction

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CREATININE; ESTROGEN; FORMALDEHYDE; GLUTARALDEHYDE; LIPOFUSCIN; PENTETATE TECHNETIUM TC 99M; TEA TREE OIL; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASTRATION; CELL SWELLING; CELL VACUOLE; CONTROLLED STUDY; DRUG MEGADOSE; ELECTRON MICROSCOPY; FEMALE; GLOMERULUS FILTRATION RATE; HISTOLOGY; HYDRONEPHROSIS; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY FUNCTION; LOW DRUG DOSE; MICROVILLUS; MITOCHONDRION; NONHUMAN; PATHOLOGY; RADIOIMMUNOASSAY; RAT; RENAL PROTECTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STAINING; UNILATERAL URETERAL OBSTRUCTION; URETER OBSTRUCTION;

EID: 84898440346     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1663     Document Type: Article

References (36)

1. Yasui T, Iguchi M, Suzuki S and Kohri K: Prevalence and epide miological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology 71: 209-213, 2008.
2. Takahashi T, Yamane A, Okasho K, et al: Incidence of upper urinary tract stone during 15 years in Tajima area, Japan: a hospital-based study. Urol Res 37: 305-310, 2009.
3. Tanagho EA: Urinary obstruction & stasis. In: Smith's General Urology. Tanagho EA and McAninch JW (eds). 17th edition. McGraw-Hill, New York, p166, 2008.
4. Mao S, Jiang H, Wu Z, et al: Urolithiasis: the most risk for nephrectomy in nonrenal tumor patients. J Endourol 26: 1356-1360, 2012.
5. Ji H, Menini S, Mok K, et al: Gonadal steroid regulation of renal injury in renal wrap hypertension. Am J Physiol Renal Physiol 288: F513-F520, 2005.
6. Fung MM, Poddar S, Bettencourt R, et al: A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study. Menopause 18: 629-637, 2011.
7. Cherikh WS, Young CJ, Kramer BF, et al: Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation. Am J Transplant 11: 1650-1655, 2011.
8. Topcu SO, Pedersen M, Nørregaard R, et al: Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction. Am J Physiol Renal Physiol 292: F736-F748, 2007.
9. Baiardi G, Macova M, Armando I, et al: Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat. Regul Pept 124: 7-17, 2005.
10. Armando I, Jezova M, Juorio AV, et al: Estrogen upregulates renal angiotensin II AT(2) receptors. Am J Physiol Renal Physiol 283: F934-F943, 2002.
11. Thompson J and Khalil RA: Gender differences in the regulation of vascular tone. Clin Exp Pharmacol Physiol 30: 1-15, 2003.
12. Sandberg K: Mechanisms underlying sex differences in progressive renal disease. Gend Med 5: 10-23, 2008.
13. Li C, Shi Y, Wang W, et al: Alpha-MSH prevents impairment in renal function and dysregulation of AQPs and Na-K-ATPase in rats with bilateral ureteral obstruction. Am J Physiol Renal Physiol 290: F384-F396, 2006.
14. Efrati S, Berman S, Chachashvili A, et al: Rosiglitazone treatment attenuates renal tissue inflammation generated by urinary tract obstruction. Nephrology (Carlton) 14: 189-197, 2009.
15. Alvarez A, Hermenegildo C, Issekutz AC, et al: Estrogens inhibit angiotensin II-induced leukocyte-endothelial cell interactions in vivo via rapid endothelial nitric oxide synthase and cyclooxy genase activation. Circ Res 91: 1142-1150, 2002.
16. Rodríguez E, López R, Paez A, et al: 17Beta-estradiol inhibits the adhesion of leukocytes in TNF-alpha stimulated human endothelial cells by blocking IL-8 and MCP-1 secretion, but not its transcription. Life Sci 71: 2181-2193, 2002.
17. Mori M, Tsukahara F, Yoshioka T, et al: Suppression by 17beta-estradiol of monocyte adhesion to vascular endothelial cells is mediated by estrogen receptors. Life Sci 75: 599-609, 2004.
18. Silbiger SR: Raging hormones: gender and renal disease. Kidney Int 79: 382-384, 2011.
19. Kang DH, Yu ES, Yoon KI and Johnson R: The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol 164: 679-688, 2004.
20. Negulescu O, Bognar I, Lei J, et al: Estradiol reverses TGF-beta1-induced mesangial cell apoptosis by a casein kinase 2-dependent mechanism. Kidney Int 62: 1989-1998, 2002.
21. Ito K, Chen J, El Chaar M, et al: Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats. Am J Physiol Renal Physiol 287: F1283-F1293, 2004.
22. Meng XM, Chung AC and Lan HY: Role of the TGF-β/BMP-7/Smad pathways in renal diseases. Clin Sci (Lond) 124: 243-254, 2013.
23. Ina, K, Kitamura, H, Tatsukawa, S and Fujikura Y: Significance of α-SMA in myofibroblasts emerging in renal tubulointerstitial fibrosis. Histol Histopathol 26: 855-866, 2011.
24. Heiman JR, Rupp H, Janssen E, et al: Sexual desire, sexual arousal and hormonal differences in premenopausal US and Dutch women with and without low sexual desire. Horm Behav 59: 772-779, 2011.
25. Curtis KS: Estrogen and the central control of body fluid balance. Physiol Behav 97: 180-192, 2009.
26. Frøkiaer J1 and Sørensen SS: Eicosanoid excretion from the contralateral kidney in pigs with complete unilateral ureteral obstruction. J Urol 154: 1205-1209, 1995.
27. Yarger WE, Schocken DD and Harris RH: Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function. J Clin Invest 65: 400-412, 1980.
28. Oelkers WK: Effects of estrogens and progestogens on the renin aldosterone system and blood pressure. Steroids 61: 166-171, 1996.
29. Gallagher PE, Li P, Lenhart JR, Chappell MC and Brosnihan KB: Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 33: 323-328, 1999.
30. Karl M, Berho M, Pignac-Kobinger J, et al: Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivo. Am J Pathol 169: 351-361, 2006.
31. Guccione M, Silbiger S, Lei J, et al: Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2. Am J Physiol Renal Physiol 282: F164-F169, 2002.
32. Zdunek M, Silbiger S, Lei J and Neugarten J: Protein kinase CK2 mediates TGF-beta1-stimulated type IV collagen gene transcription and its reversal by estradiol. Kidney Int 60: 2097-2108, 2001.
33. Neugarten J, Acharya A, Lei J and Silbiger S: Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. Am J Physiol Renal Physiol 279: F309-F318, 2000.
34. Studd J: 'PROFOX' the post HRT nightmare. Climacteric 14: 217-219, 2011.
35. Dietel M: Hormone replacement therapy (HRT), breast cancer and tumor pathology. Maturitas 65: 183-189, 2010.
36. Brown S: IMS updates its recommendations on HRT. Menopause Int 17: 75, 2011.